相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Tumor methylation patterns to measure tumor fraction in cell-free DNA.
Colin Melton et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura et al.
NATURE MEDICINE (2020)
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
J. H. Lee et al.
ANNALS OF ONCOLOGY (2019)
Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
Maaike Buskermolen et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Xiaoji Chen et al.
CLINICAL CANCER RESEARCH (2019)
Cancer overdiagnosis: a biological challenge and clinical dilemma
Sudhir Srivastava et al.
NATURE REVIEWS CANCER (2019)
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Sarah B. Goldberg et al.
CLINICAL CANCER RESEARCH (2018)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?
Xiaoliang Zhao et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
Guoqiang Tan et al.
MEDICINE (2018)
Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
Linyan Chen et al.
GENE (2018)
Universal cancer screening: revolutionary, rational, and realizable
David A. Ahlquist
NPJ PRECISION ONCOLOGY (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Jane Goodall et al.
CANCER DISCOVERY (2017)
New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases
Charles Dayen et al.
JOURNAL OF THORACIC DISEASE (2017)
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio
Kyongsun Pak et al.
JAMA ONCOLOGY (2017)
The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
Nehmat Houssami et al.
NPJ BREAST CANCER (2017)
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?
Dorota Kwapisz
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Ian J. Jacobs et al.
LANCET (2016)
Stage at diagnosis and early mortality from cancer in England
S. McPhail et al.
BRITISH JOURNAL OF CANCER (2015)
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
I. Balgkouranidou et al.
BRITISH JOURNAL OF CANCER (2014)
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
Hajime Uno et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Laura J. Esserman et al.
LANCET ONCOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Reiko Nishihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Preventing overdiagnosis: how to stop harming the healthy
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial
P. F. Pinsky et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
分享论文
